查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1617715

血紅素測試市場：按類型、技術、營運、應用、最終用戶分類 - 2025-2030 年全球預測

Hemoglobin Testing Market by Type (Blood Glucose Testing, Cyanmethemoglobin Method, Hemoglobin Electrophoresis), Technology (Laboratory Testing, Point-of-Care Testing), Operation, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年血紅素檢測市場價值為57億美元，預計2024年將達60.4億美元，複合年成長率為6.10%，預計2030年將達到86.3億美元。

血紅素檢測是醫療產業不可或缺的診斷程序，主要用於測量血液中血紅素的含量、診斷貧血、監測糖尿病等慢性病的治療效果。血紅素檢測的需求源於其在提供重要健康資訊和影響各個醫學專業領域的病患管理決策方面的作用。其應用範圍正從常規健康檢查擴展到內科、小兒科、血液科等專業醫療機構，最終用途主要是醫院、診斷實驗室和居家醫療機構。影響血紅素檢測市場的關鍵成長要素包括血液疾病盛行率的增加、老年人口的增加以及就地檢驗技術的進步。此外，對個人化醫療的日益關注以及對醫療保健的認知和積極努力的提高等趨勢也支持了市場的擴張。市場開拓機會包括開發非侵入性快速檢測、與數位健康平台整合以提高資料可近性，以及擴展到醫療基礎設施快速發展的新興市場。然而，它們面臨一些限制，例如與先進診斷設備相關的高成本以及全球在獲得醫療服務方面的差異，這可能會阻礙它們的成長潛力。嚴格的監管要求也可能對新進入造成障礙。創新可以透過專注於測試程序的進步來推動，例如提高準確性、減少患者不適以及增強非專業環境下易於使用的應用程式。部署人工智慧和巨量資料分析來改善診斷見解和患者結果也可以帶來顯著的改善。總體而言，血紅蛋白檢測市場顯示出動態成長潛力，但需要策略性地適應監管環境並投資於技術創新，以最大限度地利用機會。

主要市場統計
基準年[2023] 57億美元
預測年份 [2024] 60.4億美元
預測年份 [2030] 86.3億美元
複合年成長率（%） 6.10%

市場動態：揭示快速發展的血紅蛋白測試市場的關鍵市場洞察

供需的動態交互作用正在改變血紅蛋白檢測市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 慢性病的盛行率和定期血紅素監測的必要性
    • 提供改進的、易於使用的就地檢驗
    • 政府努力提高貧血檢測意識
  • 市場限制因素
    • 測試方法的複雜性和對專業技能的需求
  • 市場機會
    • 血紅素檢測方法的技術進步
    • 採用高性能家用血紅素檢測套組和設備
  • 市場問題
    • 對不準確和誤報的擔憂

波特五力：駕馭血紅素測試市場的策略工具

波特的五力框架是了解血紅素測試市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對血紅素檢測市場的影響

外部宏觀環境因素在塑造血紅蛋白檢測市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解血紅素檢測市場的競爭格局

血紅素測試市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：血紅素檢測市場供應商績效評估

FPNV定位矩陣是評估血紅素檢測市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製血紅素測試市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對血紅蛋白測試市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病的盛行率和定期監測血紅素濃度的必要性
      • 提供改進的使用者友善就地檢驗
      • 政府努力提高人們對貧血檢測的認知
    • 抑制因素
      • 具體測試方法的複雜性和對專業技能的需求
    • 機會
      • 血紅素檢測方法的技術進步
      • 採用高性能家用套件和設備
    • 任務
      • 對不準確和誤報的擔憂
  • 市場區隔分析
    • 類型：使用氰化高鐵血紅蛋白方法作為測量總血紅素濃度的標準且經濟有效的技術
    • 操作：首選非侵入性血紅素檢測，因為它方便且減少與採血相關的不適
    • 應用：先進的血紅蛋白測試解決方案，以確定貧血的嚴重程度
    • 最終用戶：可以使用各種血紅蛋白測試來診斷各種血液疾病
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 血紅素檢測市場：依類型

  • 介紹
  • 血糖值測試
  • 氰化高鐵血紅蛋白法
  • 血紅素電泳

第7章 血紅素檢測市場：依技術分類

  • 介紹
  • 臨床檢查
  • 就地檢驗

第8章 血紅素檢測市場：依營運分類

  • 介紹
  • 侵入性測試
    • 侵入式比色皿
    • 侵入性剝離
  • 非侵入性測試

第9章血紅素檢測市場：依應用分類

  • 介紹
  • 貧血的診斷和監測
  • 糖尿病的診斷和治療
  • 鐮狀細胞疾病篩檢
  • 地中海貧血的檢測

第 10 章 血紅素測試市場：依最終使用者分類

  • 介紹
  • 血庫
  • 診斷實驗室
  • 居家醫療
  • 醫院/診所
  • 研究所

第11章 北美和南美血紅素檢測市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區血紅素檢測市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章 歐洲、中東和非洲血紅素檢測市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Sanguina 的血紅素檢測套組獲得美國FDA 批准
    • Mylab 推出獨特的鐮狀貧血照護現場檢測
    • Hemex Health 獲得 300 萬美元津貼，以推進瞪羚 Hb 突變測試在美國市場的商業化
  • 戰略分析和建議

公司名單

  • Abcam PLC
  • ACON Laboratories, Inc.
  • AdvaCare Pharma
  • Arkray, Inc.
  • ARUP Laboratories
  • Attikouris Enterprises Ltd.
  • Avantor, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Boditech Med Inc.
  • Clarity Diagnostics, LLC
  • Cliawaived, Inc.
  • DiaSys Diagnostic Systems GmbH
  • EKF Diagnostics Holdings PLC by IBL PLC
  • F. Hoffmann-La Roche AG
  • HemoCue AB
  • Laboratory Corporation of America Holdings
  • Masimo Corp.
  • Merck KGaA
  • Nova Biomedical
  • OrSense Ltd.
  • PerkinElmer Inc.
  • Qiagen NV
  • Quest Diagnostics Incorporated
  • Siemens Healthcare GmbH
  • Sotera Health Company
  • Thermo Fisher Scientific Inc.
  • Versiti, Inc.
  • VivaChek BIoTech（Hangzhou）Co., Ltd.
Product Code: MRR-521BAA36EDBC

The Hemoglobin Testing Market was valued at USD 5.70 billion in 2023, expected to reach USD 6.04 billion in 2024, and is projected to grow at a CAGR of 6.10%, to USD 8.63 billion by 2030.

Hemoglobin testing is an essential diagnostic procedure within the healthcare industry, primarily used to measure the amount of hemoglobin in blood, diagnose anemia, and monitor treatment efficacy in chronic conditions like diabetes. The necessity for hemoglobin testing stems from its role in providing critical health information, influencing patient management decisions across various medical specialties. Applications extend from routine health check-ups to specialized care settings, spanning areas like internal medicine, pediatrics, and hematology, with end-use predominant among hospitals, diagnostic laboratories, and homecare settings. Key growth factors impacting the hemoglobin testing market include an increasing prevalence of blood disorders, growing geriatric population, and advances in point-of-care testing technology. Additionally, trends such as the heightened focus on personalized medicine, and the rise in awareness and proactive healthcare practices are propelling market expansion. Opportunities can be seized in the development of non-invasive and rapid testing methods, integration with digital health platforms for enhanced data accessibility, and expansion into emerging markets where healthcare infrastructure is evolving rapidly. However, the market faces limitations like high costs associated with advanced diagnostic equipment and varying access to healthcare services globally, which can stymie growth potential. Stringent regulatory requirements may also pose as barriers to market entry for new players. Innovation can be driven by focusing on advancements in testing procedures that improve accuracy, reduce patient discomfort, and enhance user-friendly applications for non-specialist environments. Embracing AI and big data analytics to improve diagnostic insights and patient outcomes can also lead to significant improvements. Overall, the hemoglobin testing market demonstrates dynamic growth potential, yet it necessitates strategic navigation through regulatory landscapes and investment in technological innovations to maximize opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 5.70 billion
Estimated Year [2024] USD 6.04 billion
Forecast Year [2030] USD 8.63 billion
CAGR (%) 6.10%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hemoglobin Testing Market

The Hemoglobin Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic diseases and need for regular hemoglobin level monitoring
    • Availability of improved and user-friendly point-of-care testing
    • Government initiatives promoting awareness about anemia testing
  • Market Restraints
    • Complexity of certain testing methods and need for specialized skills
  • Market Opportunities
    • Technological advancements in hemoglobin testing methods
    • Introduction of high-performing home hemoglobin testing kits and devices
  • Market Challenges
    • Concerns associated with inaccuracy and false positives

Porter's Five Forces: A Strategic Tool for Navigating the Hemoglobin Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hemoglobin Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hemoglobin Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hemoglobin Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hemoglobin Testing Market

A detailed market share analysis in the Hemoglobin Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hemoglobin Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hemoglobin Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hemoglobin Testing Market

A strategic analysis of the Hemoglobin Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hemoglobin Testing Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, ACON Laboratories, Inc., AdvaCare Pharma, Arkray, Inc., ARUP Laboratories, Attikouris Enterprises Ltd., Avantor, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Boditech Med Inc., Clarity Diagnostics, LLC, Cliawaived, Inc., DiaSys Diagnostic Systems GmbH, EKF Diagnostics Holdings PLC by IBL PLC, F. Hoffmann-La Roche AG, HemoCue AB, Laboratory Corporation of America Holdings, Masimo Corp., Merck KGaA, Nova Biomedical, OrSense Ltd., PerkinElmer Inc., Qiagen N.V., Quest Diagnostics Incorporated, Siemens Healthcare GmbH, Sotera Health Company, Thermo Fisher Scientific Inc., Versiti, Inc., and VivaChek Biotech (Hangzhou) Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Hemoglobin Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Blood Glucose Testing, Cyanmethemoglobin Method, and Hemoglobin Electrophoresis.
  • Based on Technology, market is studied across Laboratory Testing and Point-of-Care Testing.
  • Based on Operation, market is studied across Invasive Testing and Non-Invasive Testing. The Invasive Testing is further studied across Invasive Cuvette and Invasive Strip.
  • Based on Application, market is studied across Anemia Diagnosis & Monitoring, Diabetes Diagnosis & Management, Sickle Cell Disease Screening, and Thalassemia Detection.
  • Based on End-User, market is studied across Blood Bank, Diagnostic Laboratories, Homecare Settings, Hospitals & Clinics, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and need for regular hemoglobin level monitoring
      • 5.1.1.2. Availability of improved and user-friendly point-of-care testing
      • 5.1.1.3. Government initiatives promoting awareness about anemia testing
    • 5.1.2. Restraints
      • 5.1.2.1. Complexity of certain testing methods and need for specialized skills
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in hemoglobin testing methods
      • 5.1.3.2. Introduction of high-performing home hemoglobin testing kits and devices
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with inaccuracy and false positives
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Use of cyanmethemoglobin method as a standard and cost-effective technique for measuring total hemoglobin concentration
    • 5.2.2. Operation: Preference for non-invasive hemoglobin testing due to their convenience and ability to reduce discomfort associated with blood draws
    • 5.2.3. Application: Advanced hemoglobin testing solutions to determine the severity of anemia
    • 5.2.4. End-User: Availability of diverse range of hemoglobin testing to diagnose various hematological disorders
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Hemoglobin Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Blood Glucose Testing
  • 6.3. Cyanmethemoglobin Method
  • 6.4. Hemoglobin Electrophoresis

7. Hemoglobin Testing Market, by Technology

  • 7.1. Introduction
  • 7.2. Laboratory Testing
  • 7.3. Point-of-Care Testing

8. Hemoglobin Testing Market, by Operation

  • 8.1. Introduction
  • 8.2. Invasive Testing
    • 8.2.1. Invasive Cuvette
    • 8.2.2. Invasive Strip
  • 8.3. Non-Invasive Testing

9. Hemoglobin Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Anemia Diagnosis & Monitoring
  • 9.3. Diabetes Diagnosis & Management
  • 9.4. Sickle Cell Disease Screening
  • 9.5. Thalassemia Detection

10. Hemoglobin Testing Market, by End-User

  • 10.1. Introduction
  • 10.2. Blood Bank
  • 10.3. Diagnostic Laboratories
  • 10.4. Homecare Settings
  • 10.5. Hospitals & Clinics
  • 10.6. Research Institutes

11. Americas Hemoglobin Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Hemoglobin Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Hemoglobin Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Sanguina Receives US FDA Clearance for Haemoglobin Test Kit
    • 14.3.2. Mylab Introduces Indigenous Point-of-Care Sickle Cell Anaemia Test
    • 14.3.3. Hemex Health Awarded USD 3 Million Grant to Advance Commercialization of Gazelle Hb Variant Test for the U.S. market
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC
  • 2. ACON Laboratories, Inc.
  • 3. AdvaCare Pharma
  • 4. Arkray, Inc.
  • 5. ARUP Laboratories
  • 6. Attikouris Enterprises Ltd.
  • 7. Avantor, Inc.
  • 8. Becton, Dickinson and Company
  • 9. Bio-Rad Laboratories, Inc.
  • 10. Bio-Techne Corporation
  • 11. Boditech Med Inc.
  • 12. Clarity Diagnostics, LLC
  • 13. Cliawaived, Inc.
  • 14. DiaSys Diagnostic Systems GmbH
  • 15. EKF Diagnostics Holdings PLC by IBL PLC
  • 16. F. Hoffmann-La Roche AG
  • 17. HemoCue AB
  • 18. Laboratory Corporation of America Holdings
  • 19. Masimo Corp.
  • 20. Merck KGaA
  • 21. Nova Biomedical
  • 22. OrSense Ltd.
  • 23. PerkinElmer Inc.
  • 24. Qiagen N.V.
  • 25. Quest Diagnostics Incorporated
  • 26. Siemens Healthcare GmbH
  • 27. Sotera Health Company
  • 28. Thermo Fisher Scientific Inc.
  • 29. Versiti, Inc.
  • 30. VivaChek Biotech (Hangzhou) Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. HEMOGLOBIN TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. HEMOGLOBIN TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEMOGLOBIN TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEMOGLOBIN TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY BLOOD GLUCOSE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY CYANMETHEMOGLOBIN METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY HEMOGLOBIN ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE CUVETTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE STRIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY NON-INVASIVE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY ANEMIA DIAGNOSIS & MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY DIABETES DIAGNOSIS & MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY SICKLE CELL DISEASE SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY THALASSEMIA DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 282. HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023